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Vasoactive intestinal peptide (VIP) and noradrenaline (NA) 
have been previously shown to promote glycogenolysis in 
mouse cerebral cortex (Magistretti, 1990). This action, which 
is fully expressed within a few minutes, is exerted on astro- 
cytes (Sorg and Magistretti, 1991). In the present article, we 
report a second, temporally delayed, action of VIP or NA in 
primary cultures of mouse cerebral cortical astrocytes; thus, 
following glycogenolysis, an induction of glycogen resyn- 
thesis is observed, resulting, within 9 hr, in glycogen levels 
that are 6-10 times higher than those measured before the 
application of either neurotransmitter. This effect of VIP or 
NA is concentration dependent and, for NA, is mediated by 
adrenergic receptors of the B subtype. The continued pres- 
ence of the neurotransmitter is not necessary for this long- 
term effect, since pulses as short as 1 min result in the 
doubling of glycogen levels 9 hr later. The induction of gly- 
cogen resynthesis triggered by VIP or NA is dependent on 
protein synthesis, since both cycloheximide and actinomy- 
tin D abolish it entirely. The ability to elicit glycogenolysis 
is not sufficient per se to trigger the induction of glycogen 
resynthesis. Thus, two glycogenolytic agents such as meth- 
oxamine, an a,-adrenergic agonist, and phorbol 12,13-di- 
butyrate, both acting via protein kinase C activation, are 
unable to induce glycogen resynthesis. This observation, 
taken together with the fact that dibutyryl-CAMP application 
also results in enhanced glycogen resynthesis, strongly sug- 
gests that the long-term effect of VIP or NA is mediated by 
the CAMP second-messenger pathway. These results indi- 
cate that the same neurotransmitter, for example, VIP or NA, 
can elicit two actions with different time courses: (1) gly- 
cogenolysis, occurring within minutes, and (2) glycogen re- 
synthesis, fully expressed after several hours. The two ac- 
tions are mechanistically coordinated since the long-term 
one, that is, glycogen resynthesis, ensures that sufficient 
substrate is available for the expression of the short-term 
effect, that is, glycogenolysis. These results also indicate 
that the glycogen content of astrocytes in primary culture, 
a condition in which neurons are absent, can increase con- 
siderably; a parallel could therefore be drawn with the marked 
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increases in brain glycogen content, particularly in astro- 
cytes, that are observed in experimental neurodegeneration 
induced by brain trauma or x-irradiation (Shimizu and Ha- 
muro, 1958; Lundgren and Miquel, 1970). In both conditions, 
the increase in glycogen occurs in reactive astrocytes that 
have been partially or totally deprived of their neuronal en- 
vironment. 
The glycogen content of the rodent brain ranges between 20 and 
60 nmol/mg protein, depending on the region (Passonneau and 
Lauderdale, 1974; Sagar et al., 1987). In the cerebral cortex, 
glycogen levels are approximately 30 nmol/mg protein (Sagar 
et al., 1987). Glycogen is localized in astrocytes, to such an extent 
that this cell type can be positively identified at the ultrastruc- 
tural level by the presence of glycogen granules in the cytoplasm 
(Peters et al., 1991). This astrocytic glycogen pool is metabol- 
ically very active, as indicated by its rapid turnover rate (Wa- 
tanabe and Passonneau, 1973; Ibrahim, 1975; Siesjo, 1978) and 
by the fact that it is under the control of multiple regulatory 
mechanisms (Magistretti, 1988). Thus, decreased synaptic ac- 
tivity, achieved for example by anesthesia (Nelson et al., 1968; 
Brunner et al., 1971; Passonneau et al., 1971), markedly in- 
creases the glycogen content of the brain, particularly in astro- 
cytes (Phelps, 1972). Administration ofthe glutamine synthetase 
inhibitor methionine sulfoximine has similar effects (Phelps, 
1975). Glycogen levels are also increased during slow-wave sleep 
(Kamovsky et al., 1983). Under normal conditions, glycogen is 
hardly visible at the light microscopic level using standard stain- 
ing procedures (Shimizu and Hamuro, 1958). However, a com- 
mon finding reported following lesions of the brain parenchyma 
either of traumatic origin, for example, stab wound (Shimizu 
and Hamuro, 1958; Hager et al., 1967; Haymaker et al., 1970; 
Watanabe and Passonneau, 1974; Al-Ali and Robinson, 1982) 
or by x-ray irradiation (Wolfe et al., 1962; Lundgren and Miquel, 
1970) is a massive deposition of glycogen granules, predomi- 
nantly in glial cells at the periphery of the lesioned area. These 
histochemical observations have been confirmed by biochem- 
ical measurements of glycogen levels following brain trauma, 
which indicate an early (i.e., within 10 min) decrease followed 
by a delayed increase in glycogen after 2.5-24 hr (Watanabe and 
Passonneau, 1974). Another neurodegenerative condition in 
which glycogen accumulations are observed, particularly in the 
cerebral cortex, is Alzheimer’s disease (Mann et al., 1987). Brain 
glycogen levels are also under the tight control of numerous 
neurohumoral factors (Magistretti, 1988). Thus, the monoam- 
ines noradrenaline (NA), histamine, and serotonin (5-HT) (Quach 
et al., 1978, 1980, 1982), as well as adenosine and the peptide 
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Figure I. Time course of the effects of VIP on glycogen levels. VIP (1 
PM) was applied for various periods of time. The inset shows in detail 
the curve for short periods of VIP application. Results are the mean f  
SEM of quadruplicate determinations from one experiment, repeated 
once with similar results. 
vasoactive intestinal peptide (VIP), exert a potent glycogenolytic 
action in slices of the cerebral cortex (Magistretti et al., 198 1, 
1986; Hof et al., 1988). More recently, most of these neuro- 
transmitters have been shown to promote glycogenolysis in pri- 
mary cultures of astrocytes (Sorg and Magistretti, 199 1). In con- 
trast, in this cellularly homogeneous preparation, insulin (Dringen 
and Hamprecht, 1992), glutamate, and methionine sulfoximine 
but not phenobarbital (Swanson et al., 1989, 1990) increase in 
a time- and concentration-dependent manner the glycogen con- 
tent. These observations led us to propose that the primary 
action of certain neurotransmitters such as VIP or NA may be 
to regulate local energy homeostasis within the CNS by acting 
on non-neuronal cells such as astrocytes (Magistretti, 1990,199 1). 
From the foregoing set of observations, it is clear that the me- 
tabolism of brain glycogen occurs predominantly in astrocytes 
and that it is more dynamically regulated than previously thought. 
As a further indication of the plasticity of brain glycogen 
metabolism, we report in the present article on a study con- 
ducted in primary cultures of mouse cerebral cortical astrocytes, 
in which two opposed and temporally regulated actions of a 
single neurotransmitter on glycogen levels are demonstrated. 
Thus, in addition to promoting glycogenolysis within a few min- 
utes (Sorg and Magistretti, 1991), VIP or NA markedly stim- 
ulates the resynthesis of glycogen, resulting in a delayed increase 
in the glycogen content of astrocyte cultures. This long-term 
action of VIP or NA is sensitive to protein synthesis inhibition. 
Materials and Methods 
Cell culture. Primary cultures of cerebral cortical astrocytes were pre- 
pared from Swiss Albino newborn mice (l-2 d old) as previously de- 
scribed (McCarthy and de Vellis, 1980; Sorg and Magistretti, 1991). 
Briefly, forebrains were removed aseptically from the skulls, the me- 
ninges were excised carefully, and the neocortex was dissected. The cells 
were dissociated by passage through needles of decreasing gauges (1.2 
x 40 mm, 0.8 x 40 mm, and 0.5 x 16 mm) with a 5 ml syringe. No 
trypsin was used for dissociation. The cells were seeded at a density of 
10S/cm2 on six-well plates (Sterilin) in DMEM (Dulbecco’s Modified 
Eagle’s Medium) containing 10% fetal calf serum (FCS), in a final vol- 
ume of 2 ml per well, and incubated at 37°C in an atmosphere containing 
5% CO, at a 95% humidity. The culture medium was renewed after 4 
d of seeding and subsequently twice per week. This procedure yields 
Table 1. Induction of glycogen resynthesis elicited by VIP as a 
function of pulse duration 
Pulse duration 
Glycogen levels 
(nmoVmg protein) 
Experiment 1 
0 35 iz 7 
10 min 149 & 18 
30 min 396 t- 29 
1 hr 382 + 25 
2 hr 381 + 13 
9 hr 507 * 12 
Experiment 2 
0 27 k 5 
1 min 60 k 4 
5 min 69 k 4 
15 min 106 + 7 
30 min 135 -t 4 
9 hr 365 k 16 
VIP (1 PM) was added for various periods of time. The medium was replaced with 
one not containing the neurotransmitter, and glycogen levels were assayed 9 hr 
after the beginning of VIP application. Results are the mean 2 SEM of quadru- 
plicate determinations for each separate experiment. 
cultures in which 85-90% of cells are immunoreactive for glial fibrillary 
acidic protein (Stoyanov et al., 1988). 
Glycogen assay. After 14-2 1 d in culture, the cells reached confluence 
and were used for the glycogen assay, as previously described (Sorg and 
Magistretti, 1991). Culture medium was replaced with a serum-free 
DMEM containing 5 mM glucose (instead of 25 mM for the culture 
medium). Four hours after having replaced the medium, pharmacolog- 
ical agents were added for various periods of time, during which cultures 
were maintained in the incubator.-The reaction was stopped by washing 
the cells with ice-cold PBS (phosphate-buffered saline), and by adding 
2 ml of 30 mM HCl. The cells were son&ted and the susuension was 
used to measure glycogen as described by Nahorski and Rogers (1972). 
Briefly, three 100 pl aliquots were sampled. In the first aliquot, 300 ~1 
of acetate buffer were added. In the second, 300 ~1 of a solution con- 
taining 10% of amyloglucosidase (10 mg/ml) in acetate buffer (0.1 M, 
pH 4.65) were added, and the mixture was incubated at room temper- 
ature for 30 min. After incubation with amyloglucosidase, 2 ml ofTris 
HCl buffer (0.1 M, pH 8.1) containing MgCl, (3.3 mM), ATP (0.2 mM), 
NADP (25 &ml), hexokinase (4 &ml), and glucose-6-phosphate de- 
hydrogenase (2 &ml) were added, and the mixture was incubated at 
room temperature for 30 min. The first aliquot was treated identically. 
The fluorescence of the NADPH formed was then read on a fluorometer 
(excitation, 340 nm; emission, 450 nm). The first aliquot gives the sum 
of glucose and glucose-6-phosphate, while the second gives the sum of 
glycogen, glucose, and glucose-6-phosphate; the amount of glycogen is 
then determined by the difference between the first two aliquots. The 
third aliquot was used to measure the protein content with the method 
of Bradford (1976). We should note that in this report, 1 mol of glycogen 
means 1 mol of glycosyl unit originating from glycogen. 
ATP, NADP. and the enzvmes were nurchased from Boehrinmr 
Mannheim; VIP, from Bachem (Bubendorf, Switzerland); and all other 
reagents, from Sigma Chemical Co. (St. Louis, MO). 
Statistical analyses were performed by the Student’s t test. 
Results 
Application of VIP to primary cultures of mouse astrocytes 
results in two, time-dependent, effects on glycogen levels. During 
the first hour of application, the previously described (Sorg and 
Magistretti, 199 1) glycogen hydrolysis is observed, leading to a 
virtually complete disappearance of glycogen from the cultures 
(Fig. 1, inset). From 1 hr on, a time-dependent resynthesis of 
glycogen occurs, resulting, within the third hour of incubation, 
in glycogen levels similar to those measured prior to the appli- 
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Figure 2. Effect of various glycogenolytic agents on glycogen resyn- 
thesis. Agents were applied for 30 min, the medium was replaced with 
one not containing the agents, and glycogen levels were assayed 8hr 30 
min later. Results are the mean + SEM of quadruplicate determinations 
from one experiment, repeated twice for methoxamine and isoproter- 
enol, three times for PdBu, seven times for dBcAMP, and 16 times for 
NA, with similar results. a, glycogen levels significantly different from 
control (p 4 0.01); b, glycogen levels not significantly different from 
control (p > 0.01). 
cation of VIP (Fig. 1). However, most unexpectedly, glycogen 
levels continue to rise until at least 8 hr, reaching levels 6-10 
times higher than those present in the cultures under basal con- 
ditions (Fig. 1). This induction of glycogen resynthesis is re- 
versible, since basal levels are reached within 48 hr (Fig. 1). 
A puzzling consideration made in light of these results was 
that the stimulation of glycogen resynthesis could occur despite 
the continuous presence of a glycogenolytic neurotransmitter 
such as VIP. This fact led us to wonder whether the sustained 
exposure of the cultures to VIP was necessary or if a brief ap- 
plication of the peptide could also result in a delayed increase 
in glycogen levels. To test this possibility, we applied VIP pulses 
of various duration, changed the medium to remove the peptide, 
and measured glycogen levels 9 hr after the beginning of the 
exposure to VIP. As shown in Table 1, pulses of VIP as short 
as 10 min resulted, 9 hr later, in glycogen levels four times higher 
than those obtained under basal conditions. Even a 1 min pulse 
could approximately double glycogen levels (Table 1). In view 
of the foregoing observations, VIP pulses of 10 or 30 min were 
used in all further experiments. 
At this stage of our analysis, the question was raised ofwheth- 
er the induction of glycogen resynthesis that followed VIP ap- 
plication was simply the consequence of the glycogenolytic ac- 
tion of the peptide or whether glycogenolysis and induction of 
glycogen synthesis could be dissociated. Results presented in 
Figure 2 clearly indicate that the latter mechanism occurs. Thus, 
methoxamine, an a,-adrenergic agonist that promotes phos- 
phatidylinositol turnover, and phorbol 12,13-dibutyrate (PdBu), 
a direct activator of protein kinase C (PKC), both promote 
glycogenolysis without overinducing glycogen synthesis. In con- 
trast, NA and the /3-adrenergic agonist isoproterenol, as well as 
dibutyryl-CAMP (dBcAMP), that is, three pharmacological agents 
that, like VIP, increase CAMP levels in astrocytes and promote 
a short-term glycogenolysis, all cause a marked overinduction 
of glycogen synthesis (Fig. 2). 
The effect of VIP or NA in stimulating glycogen resynthesis 
is concentration dependent, becoming significant at concentra- 
tions over 100 nM for both neurotransmitters (Fig. 3). 
300 
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Figure 3. Concentration-response curves of the induction of glycogen 
resynthesis induced by VIP (A) and NA (B). VIP or NA were applied 
for 30 min, the medium was replaced with one not containing the 
neurotransmitters, and glycogen levels were assayed 8hr 30 min later. 
Results are the mean & SEM of quadruplicate determinations from one 
experiment, repeated once with similar results. 
Given the temporally delayed nature of glycogen synthesis 
over-induction promoted by VIP or NA, we considered the pos- 
sibility that protein synthesis could be needed to elicit the ob- 
served effect. As shown in Figure 4A, this mechanism is likely 
to be operative, since inhibition of translation by cycloheximide 
(CX) completely inhibits the VIP- and NA-stimulated glycogen 
resynthesis. Experiments were carried out as follows: CX (100 
I.LM) was applied 1 hr prior to a 30 min pulse of VIP or NA. 
After replacing the medium to remove VIP or NA, CX was 
added again at the same concentration, and glycogen was de- 
termined 8 hr and 30 min later. Figure 4A also shows that 
prolonged (up to 10 hr) exposure to CX at 100 PM is not toxic 
to astrocytes, at least as far as glycogen is used as an index, since 
levels of the polysaccharide in control and CX-treated cultures 
were not significantly different. However, a consistent obser- 
vation was a marked decrease in glycogen levels in the cultures 
exposed to the glycogenolytic neurotransmitters in the presence 
of CX (Fig. 4A). Inhibition of transcription by actinomycin D 
at a concentration of 1 PM resulted in a similar inhibition of 
glycogen resynthesis elicited by VIP or NA (not shown). 
In view of the known stimulating action of insulin on liver 
glycogen synthesis and of the previously described presence of 
insulin receptors functionally coupled to glucose transport in 
cultured astrocytes (Clarke et al., 1984), we examined the effect 
of insulin on glycogen levels. As shown in Figure 5B, incubation 
of astrocytes in the presence of insulin for 9 hr results in a 
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Figure 4. Suppression by cycloheximide (CX) of the induction by VIP 
(A), NA (A), or insulin (B) of glycogen resynthesis. CX (100 PM) was 
added 1 hr before application of VIP (1 PM), NA (100 PM), or insulin 
(1 PM); the neurotransmitters and insulin were maintained for 30 min; 
the medium was then replaced and CX added again; 8 hr 30 min later, 
glycogen levels were assayed. Results are the mean + SEM of quad- 
ruplicate determinations from one experiment, repeated once with sim- 
ilar results. a, glycogen levels significantly higher than control (p < 
0.01); b, glycogen levels not significantly different from control (p > 
0.01); c, glycogen levels significantly lower than control (p < 0.01). 
concentration-dependent increase in glycogen levels. The effect 
is, however, less pronounced than that observed with NA or 
VIP, since over a number of separate experiments (n = 5), 
glycogen levels reached only two to three times control values, 
unlike the 6-l O-fold increase consistently observed with NA or 
VIP. The effect of insulin is unidirectional (i.e., no glycogenolysis 
is elicited) as well as time dependent, with significant increases 
observed after 2 hr (Fig. 5A). The continuous presence of insulin 
is not necessary to stimulate glycogen synthesis. Thus, as shown 
in Figure 4B, a 30 min pulse of insulin (1 PM) can promote 
glycogen synthesis as measured 8 hr and 30 min later. As for 
NA and VIP, the effect of insulin, applied as a 30 min pulse, is 
abolished by CX (Fig. 4B). 
The foregoing observations clearly indicated that glycogen 
levels could be increased up to lo-fold by brief exposure to 
appropriate agents. Since protein synthesis appeared to be in- 
volved in this phenomenon, we wondered whether other po- 
tential alterations in cell function reflected by the conversion of 
astrocytes from low- (40-80 nmol/mg protein) versus high- (300- 
600 nmol/mg protein) glycogen-containing cells would affect the 
glycogenolytic action of neurotransmitters. To this end, we ex- 
amined glycogen hydrolysis elicited by VIP or NA in cultures 
pretreated for 48 hr with 1 mM dBcAMP, a treatment previously 
I I 
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Figure 5. Effect of insulin on glycogen levels. A, Time course. Insulin 
was applied at 1 NM for increasing periods of time. B, Concentration- 
response curve. Insulin was applied for 9 hr at various concentrations. 
Results are the mean + SEM of quadruplicate determinations from one 
experiment, repeated twice with similar results. The effect of insulin (1 
PM) after application for 9 hr was measured in four other separate 
experiments. 
shown to increase glycogen levels six- to eightfold (Sorg and 
Magistretti, 199 1). As shown in Figure 6, A and B, VIP or NA 
effectively hydrolyzed glycogen with EC,, values of 3 and 50 
nM, respectively, which are values very similar, if not identical 
in the case of VIP, to those previously reported in cultures 
containing low glycogen levels, that is, around 30 nmol/mg pro- 
tein (Sorg and Magistretti, 199 1) instead of 284 (Fig. 6A) or 659 
(Fig. 6B). A kinetic analysis of VIP- and NA-induced glycogen- 
olysis in high-glycogen containing astrocytes indicates an initial 
rate of hydrolysis of 8 and 6 nmol/mg/min protein, respectively 
(Fig. 7A,B), which are values remarkably similar to those ob- 
served in low-glycogen-containing cells (Sorg and Magistretti, 
199 1). However, an important quantitative difference exists be- 
tween the two conditions: in cultures containing low levels of 
glycogen, the rate of hydrolysis is linear for 2-5 min, reaches 
an asymptote within 10 min, and results in 60-80 nmol of 
glycogen/mg protein hydrolyzed over 30 min (Sorg and Mag- 
istretti, 199 1). In contrast, in cultures with a high glycogen con- 
tent, the initial rate of hydrolysis is linear over a 30 min period, 
resulting in 200-250 nmol of glycogen/mg protein hydrolyzed 
(Fig. 7A, B). 
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Figure 6. Concentration-response curves of the glycogenolytic effect 
of VIP (A) and NA (B) after a pretreatment with dBcAMP. Cultures 
were pretreated for 48 hr with 1 mM dBcAMP. The day of experiment, 
the medium was replaced by the standard one (5 mM glucose, no FCS, 
no dBcAMP); 4 hr later, various concentrations of VIP or NA were 
applied for 30 min. Basal glycogen levels were 284 ? 6 (A) and 659 + 
14 (B) nmol/mg protein for VIP and NA, respectively. Results are the 
mean k SEM of quadruplicate (A) and triplicate (II) determinations 
from one experiment, repeated twice (A) with similar results. 
Discussion 
Results reported in the present study indicate that a given neu- 
rotransmitter can exert two opposed effects on glycogen levels 
in astrocytes. Thus, in addition to their well-documented gly- 
cogenolytic action (Sorg and Magistretti, 1991), VIP or NA 
induce glycogen resynthesis (Fig. 1). This action of VIP or NA 
occurs after glycogenolysis and can be triggered by brief exposure 
of the cultures to the neurotransmitters (Table 1). Interestingly, 
however, the ability of promoting glycogen hydrolysis and gly- 
cogen synthesis can be dissociated. Thus, methoxamine, an (Y,- 
adrenergic agonist with glycogenolytic properties (Sorg and 
Magistretti, 199 l), does not stimulate glycogen resynthesis (Fig. 
2). Similarly, glycogenolysis triggered by PdBu (Sorg and Mag- 
istretti, 1991) is not followed by the induction of glycogen re- 
synthesis (Fig. 2). a,-adrenergic receptors are coupled to the 
phosphatidylinositol cascade that leads to PKC activation, and 
PdBu is a direct activator of PKC, while VIP and P-adrenergic 
receptors activated by isoproterenol promote CAMP formation 
(Quik et al., 1978). From the foregoing, it can be concluded that 
CAMP, and the subsequent activation of protein kinase A (PKA), 
triggers both glycogenolysis and glycogen resynthesis, while PKC 
activation is involved only in glycogenolysis. This is also con- 
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Figure 7. Time course of the glycogenolytic effect of VIP (A) and NA 
(L?) after a pretreatment with dBcAMP. Cultures were pretreated for 48 
hr with 1 mM dBcAMP. The day of experiment, the medium was re- 
placed by the standard one (5 mM glucose, no FCS, no dBcAMP); 4 hr 
later, 1 PM VIP or 100 PM NA was applied for various periods of time. 
Results are the mean f  SEM of triplicate determinations from one 
experiment, repeated once with similar results. 
firmed by the dual action of dBcAMP, that is, stimulation of 
glycogen hydrolysis and resynthesis (Fig. 2; Sorg and Magistretti, 
1991). A corollary to these comments is that induction of gly- 
cogen resynthesis is not the obligatory consequence of glyco- 
genolysis. Furthermore, as illustrated by insulin, induction of 
glycogen synthesis may also occur without previous glycogen 
hydrolysis (Fig. 5B). The possible function of insulin in the brain 
has been long debated. Binding sites have been identified (Roth 
et al., 1986; Rosenfeld et al., 1987), and in particular functional 
receptors coupled to increased 3H-2-deoxyglucose uptake have 
been demonstrated in cultured astrocytes (Clarke et al., 1984). 
Insulin-like immunoreactivity has been detected in the brain 
(Baskin et al., 1987; Wood et al., 1989), and an increase in 
glycogen levels, following insulin application in vitro to olfactory 
bulb slices, has been demonstrated (Coopersmith and Leon, 
1987). Furthermore, a recent report has indicated a stimulatory 
effect of insulin on glycogen synthesis in astrocyte cultures (Drin- 
gen and Hamprecht, 1992) in a manner very similar to the 
observations reported here. Thus, a near doubling in glycogen 
levels was observed within 2 hr of insulin application, with an 
EC,, in the low nanomolar range (Fig. 5A,B, Dringen and Ham- 
precht, 1992). In contrast to the present report, however, the 
effect of insulin was revealed in cultures that had been starved 
of glucose for 2 hr, a treatment that decreased intracellular gly- 
cogen content by approximately 80% of normal levels (Dringen 
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and Hamprecht, 1992). In our study, we demonstrate that the 
effect of insulin is expressed in the presence of physiological 
concentrations of glucose. Furthermore, we have observed that 
a 30 min pulse of insulin is sufficient to promote glycogen syn- 
thesis through a mechanism that is sensitive to protein synthesis 
inhibition (Fig. 4B). Taken together, results reported here and 
in previous studies further stress the metabolic role played by 
insulin, or by insulin-like molecules, within the nervous system. 
The effect of VIP, NA and also of insulin in increasing gly- 
cogen levels is observed, with a temporal delay, even after a 
brief application to the cultures. Thus, it is striking to note that 
a 1 min pulse of VIP leads to the doubling of glycogen levels 
within 9 hr after application. This observation strongly indicates 
that a cascade of events is triggered by the neurotransmitter, 
which progresses independent of receptor occupation. A likely 
step in this cascade of events is the increase in CAMP levels. 
Experiments in our laboratory indicate that following VIP ap- 
plication to astrocyte cultures, CAMP levels peak at 10 min and 
return to basal levels within 1 hr (P. J. Magistretti, M. Maillard, 
and J. L. Martin, unpublished observations). Evidence has been 
provided in recent years indicating that PKA can phosphorylate, 
among a number of substrates, a transcription factor called CREB 
(CAMP-responsive element-binding protein), which acts on spe- 
cific DNA sequences, that is, CAMP-responsive elements, to 
regulate the expression of certain genes (Yamamoto et al., 1988; 
Montminy et al., 1990; Sheng et al., 1990). A clear example is 
the regulation by CAMP of the gene encoding for somatostatin 
(Gonzalez and Montminy, 1989) and for a number of G-pro- 
tein-coupled membrane receptors, such as the substance P or 
the P-adrenergic receptors (Hershey et al., 1991; Collins et al., 
1992). The fact that the increase in glycogen levels elicited by 
VIP or NA, two neurotransmitters that promote CAMP for- 
mation in astrocytes, is temporally delayed and sensitive to 
agents that inhibit DNA transcription and RNA translation 
strongly suggests that the synthesis of one or more enzymes 
involved in glycogen anabolism might be the molecular mech- 
anism underlying the effect of VIP and NA. A number of en- 
zymes are potential candidates for such regulation. Thus, gly- 
cogen synthase transcription could be enhanced by VIP or NA. 
Furthermore, since the activity of glycogen synthase is de- 
creased, while that of phosphorylase is enhanced by phosphor- 
ylation, induction by VIP or NA of mRNA transcripts for phos- 
phatases and their subsequent translation can also be envisioned. 
The dephosphorylation of glycogen synthase and phosphorylase 
that would result from increased phosphatase activity would 
favor glycogen synthesis. As to the effect of insulin, the synthesis 
of a number of mRNAs has been shown to be enhanced by the 
peptide in peripheral tissues, although the cascade of intracel- 
lular events leading to such effects is still largely unknown (Sa- 
saki et al., 1984). 
To begin to tackle the functional significance of increased 
glycogen content in astrocytes, the glycogenolytic effect of VIP 
or NA in cultures in which glycogen levels had been increased 
four- to sixfold by treatment with dBcAMP was examined. Anal- 
ysis of the time and concentration dependence of the glycogen- 
olytic action exerted by VIP or NA under those conditions 
clearly indicates that the potency of both neurotransmitters, as 
well as the rate/minute of glycogen hydrolysis, is virtually iden- 
tical in astrocytes with low (Sorg and Magistretti, 1991) and 
high (Figs. 6A,B, 7A,B) glycogen content; however, the initial 
rate is maintained for at least 30 min in glycogen-rich astrocytes, 
indicating that considerably more glycosyl units are released. 
As a comparison, in astrocytes containing low glycogen levels, 
30-80 nmoles of glycogen per mg of protein are hydrolyzed 
within the first 30 min after VIP or NA application, while in 
glycogen-rich astrocytes this value ranges between 200 and 250 
(Fig. 7A,B). The question can therefore be raised of which of 
the two types of cultures reflects more closely in vivo conditions. 
The glycogen content of whole rodent brain ranges between 20 
and 60 nmol/mg protein (Passonneau and Lauderdale, 1974; 
Sagar et al., 1987); a recent report in which microwave irradi- 
ation was used as an improved inactivation procedure indicated 
glycogen levels of 33 nmol/mg protein in rat cerebral cortex 
(Sagar et al., 1987). Under the experimental conditions used in 
this study, the mean glycogen content of primary astrocyte cul- 
tures was 62 f 8 (n = 60), a value in good agreement with other 
recent reports (Swanson et al., 1989, 1990; Dringen and Ham- 
precht, 1992). When expressing the results of glycogen content 
in vivo per milligram of protein, one should bear in mind that 
glycogen is predominantly contained in astrocytes (Sotelo and 
Palay, 1968; Vaughn and Grieshaber, 1972), while other cells, 
namely neurons, which contain virtually no glycogen, contribute 
to the measured proteins. This means that in vivo studies un- 
derestimate the glycogen content of astrocytes, the question be- 
ing by what factor. Since astrocytes constitute approximately 
half of the volume of the cerebral cortex (Kimelberg and No- 
renberg, 1989; Bignami, 1991; Peters et al., 199 l), one could 
roughly estimate that glycogen content of astrocytes in vivo to 
be about 50-60 nmol/mg protein, that is, twice the value ob- 
tained when expressing the results by taking into account the 
protein content of cells that contain virtually no glycogen. An 
even more conservative estimate can be made by considering 
the fact that astrocytes outnumber neurons in the gray matter 
by approximately a factor of 10 (Bignami, 199 1; Peters et al., 
199 1). This would indicate that levels of glycogen measured in 
vivo and expressed per milligram of protein should be corrected 
by only 10% to estimate astrocytic glycogen in vivo. Regardless 
of the correction factor used, it is clear that glycogen levels 
measured in the cultures after induction by VIP or NA, that is, 
values ranging between 250 and 600 nmol/mg protein, are con- 
siderably higher than those estimated in vivo. 
What is, then, the significance of the induction of high gly- 
cogen levels by VIP or NA? One consideration that can be made 
is that astrocytes present in the cultures have not been exposed 
to neurotransmitters for 2-3 weeks, in contrast to their in vivo 
counterparts. Application of VIP or NA to neurotransmitter- 
naive astrocytes could therefore trigger the expression of de- 
velopmentally regulated processes that result in glycogen levels 
normally found in the fully differentiated astrocytes present in 
vivo. However, as discussed earlier, the levels of glycogen in vivo 
are similar, after appropriate correction, to those observed in 
neurotransmitter-naive cultures rather than to those measured 
in cultures treated with VIP or NA. These considerations would 
therefore tend to discard the possibility that neurotransmitter- 
naive astrocytes are brought, by the exposure to VIP or NA, to 
a state of differentiation that results in glycogen levels observed 
in vivo. An obvious difference between the situation in vivo and 
in primary astrocyte cultures is that in the latter condition, 
neurons are missing. It is therefore likely that a subtle interplay 
between the glycogenolytic and synthetic effects of VIP or NA 
released in vivo, according to precise spatial and temporal mo- 
dalities, results in levels of glycogen dynamically equilibrated 
around 30 nmol/mg of protein, that is, levels that are similar 
to those measured in unstimulated astrocytes in vitro. It is also 
likely that other neuronally generated signals contribute to the 
stabilization of glycogen to the levels encountered in vivo. How- 
ever, when astrocytes are exposed in vitro to VIP or NA in the 
absence of neurons, the full potential of the glycogen-synthetic 
effect of the two neurotransmitters is expressed undisturbed to 
yield glycogen levels in the hundreds of nmoles per milligram 
of protein. Slowly, however, that is, within 48 hr, the glycogen 
content of astrocytes returns to basal levels (Fig. 1). 
These considerations may have a bearing to the increased 
glycogen content that is frequently encountered in certain types 
of reactive astrocytes, in particular following traumatic lesions 
of the brain parenchyma (Shimizu and Hamuro, 1958; Hager 
et al., 1967; Haymaker et al., 1970; Watanabe and Passonneau, 
1974; Al-Ali and Robinson, 1982) and a-particle or x-irradia- 
tion (Wolfe et al., 1962; Lundgren and Miquel, 1970). Under 
these conditions, astrocytes, notably those that surround the 
lesioned area where neuronal death has occurred, are enriched 
in glycogen as assessed biochemically (Watanabe and Passon- 
neau, 1974) and visualized by light and electron microscopy 
(Hager et al., 1967; Al-Al1 and Robinson, 1982). The time course 
of the changes in glycogen levels has been examined following 
stab wounds in rat cerebral cortex (Watanabe and Passonneau, 
1974). Within few minutes after the lesion, the glycogen content 
is markedly decreased. Concomitantly, CAMP levels reach peak 
values that are sevenfold higher than the control, returning to 
basal levels within 1 hr. In contrast, glycogen accumulation 
follows the initial decrease, reaching, already at 2.5 hr, values 
that are 2.5fold higher than control levels (Watanabe and Pas- 
sonneau, 1974). This increase in glycogen content in the vicinity 
of the lesion is maintained for at least 24 hr. The temporal 
pattern of glycogen decrease followed by increased glycogen 
deposition is strikingly similar to results reported in this article. 
Another study has indicated that localized lesions ofthe cerebral 
cortex caused by needle penetration result in an increase in 
glycogen levels not only at the site of reactive gliosis surrounding 
the insult, but also at distant sites throughout the neocortical 
mantle (Haymaker et al., 1970). Marked glycogen increases are 
also observed following inhibition of synaptic transmission by 
general anesthetics, that is, another condition in which neuron- 
ally generated signals to astrocytes are likely to be decreased 
(Nelson et al., 1968; Brunner et al., 1971; Passonneau et al., 
197 1). Recently, blockade of action potentials in the afferent 
nerve has been shown to produce reactive astrocytes in the chick 
cochlear nucleus (Canady and Rubel, 1992). It would be of 
interest to determine whether these reactive astrocytes also con- 
tain high glycogen levels. 
The role of astrocytic glycogen in neural function has not yet 
been fully clarified. As noted earlier, the decrease in neuronal 
activity caused by lesions or by general anesthesia, markedly 
increases the glycogen content of astrocytes, indicating that un- 
der conditions of physiological synaptic activity, the turnover 
of the polysaccharide is rapid. In line with this view is the 
presence of corpora amylacea, that is, spherical bodies of lo- 
15 pm diameter revealed by standard glycogen stains, that are 
found in fibrous astrocytes of normal aging brains and in certain 
neurodegenerative disorders (Hume Adams et al., 1984). Like 
other cytoplasmic inclusions collectively denominated polyglu- 
cosan bodies (Robitaille et al., 1980; Thomas et al., 1980) such 
as Lafora and Bielschowsky bodies or amylopectin bodies of 
type IV glycogenosis, corpora amylacea are constituted by glu- 
cose polymers, implying that they are similar, if not identical, 
to glycogen. The mechanisms that lead to the accumulation of 
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Figure 8. Bidirectional effects of VIP or NA on glycogen in astrocytes. 
With the short-term effect, within minutes after application, VIP or NA 
promote glycogenolysis. This effect is due to CAMP-dependent phos- 
phorylation of-preexisting proteins. With the long-term effect, within a 
few hours after application of VIP or NA, glycogen levels are increased 
6-10 times above control levels. This effect is due to CAMP-dependent 
induction of new protein synthesis. 
such glycogen-containing inclusions in astrocytes are unknown. 
It is conceivable that in pathological situations in which neu- 
ronal activity is decreased, glucose supplied by the circulation 
is in considerable excess of either the capacity of astrocytes to 
hydrolyze glycogen under the action of neurotransmitters such 
as VIP and NA, or of the energy requirements of the brain 
parenchyma. Supporting this view is the observation of in- 
creased glycogen deposition in cortical astrocytes of patients 
afflicted by Alzheimer’s disease (Mann et al., 1987), a condition 
in which a considerable loss of neurons is at the forefront of the 
histopathological diagnosis (Hume Adams et al., 1984). 
As previously reviewed, it is clear that glycogen represents an 
energy substrate reserve under the tight control of various neu- 
rotransmitters, including VIP and NA (Magistretti, 1990). In 
passing, one can note that the initial velocity of the glycogen- 
olysis elicited by VIP or NA, that is, 7-9 nmol/mg protein/min 
(Sorg and Magistretti, 199 l), is of the same order of magnitude 
as the glucose utilization of the rodent cerebral cortex measured 
with the 2-deoxyglucose technique, that is, 1 O-l 6 nmol/mg pro- 
tein/min (Sokoloff et al., 1989). This correlation would tend to 
indicate that glycogen hydrolysis evoked by neurotransmitters 
may provide, in a quantitatively significant manner, energy sub- 
strates for neuronal function. 
Regardless of the possible implications in brain pathophysi- 
ology, results reported in this study clearly indicate that the two 
neurotransmitters VIP and NA exert actions on glycogen me- 
tabolism, which, while appearing opposite in nature at super- 
ficial analysis, may in fact be endowed with a functional and 
teleologically directed complementarity. Thus, by increasing 
CAMP levels, VIP or NA simultaneously trigger a short-term 
effect, that is, glycogenolysis, as well a delayed one, that is, 
transcriptionally regulated glycogen resynthesis. This longer-term 
effect ensures that sufficient substrate is available for the 
continued expression of the short-term action of VIP or NA 
(Fig. 8). 
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